|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/568 | (2006.01) |
| A61K 9/4858 | (2013.01) | ||
| A61P 5/24 | (2006.01) | ||
| A61K 31/568 | (2013.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61P 5/24 | (2018.01) | ||
| A61K 9/20 | (2006.01) |
| (11) | Patento numeris | 3548037 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17876230.8 |
| Europos patento paraiškos padavimo data | 2017-11-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-10-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-07-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/064083 |
| Data | 2017-11-30 |
| (87) | Numeris | WO 2018/102618 |
| Data | 2018-06-07 |
| (30) | Numeris | Data | Šalis |
| 201662428167 P | 2016-11-30 | US | |
| 201662428317 P | 2016-11-30 | US |
| (72) |
CHIDAMBARAM, Nachiappan , US
NACHAEGARI, Satish Kumar , US
PATEL, Mahesh V. , US
KIM, Kilyoung , US
|
| (73) |
Lipocine Inc. ,
675 Arapeen Drive Suite 202, Salt Lake City, UT 84108,
US
|
| (54) | ORAL TESTOSTERONE TRIDECANOATE THERAPY |
| ORAL TESTOSTERONE TRIDECANOATE THERAPY |